KCPG
GNMX

Kavar Capital Partners Group’s Aevi Genomic Medicine Inc GNMX Stock Holding History

Kavar Capital Partners Group’s Portfolio GNMX Stock Details GNMX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
2019
Q2 		$1K Buy
2018
Q3 		– Sell
2018
Q2 		$2K Hold
2018
Q1 		$3K Buy
2016
Q1 		– Sell
2015
Q4 		$9K Hold
2015
Q3 		$11K Hold
2015
Q2 		$9K Buy
2014
Q2 		– Sell
2014
Q1 		$13K Hold
2013
Q4 		$11K Buy